Vaccines, Blood & Biologics
OraQuick Rapid HIV-1 Antibody Test
Applicant: OraSure Technologies, Inc, Bethlehem, PA
Product: OraQuick Rapid HIV-1 Antibody Test
PMA number: BP010047
Approval Date: 9/5/2003
PMA number: BP010047/7
Indication for Use: Allow for a labeling claim for the detection of antibodies to HIV-1 in venipuncture whole blood specimens and to reduce the maximum read time from 60 minutes to 40 minutes.
September 5, 2003 Approval Letter
Package Insert (PDF - 1.81 MB)
Approval Date: 11/7/2002
PMA number: BP010047
Indication for Use: Detection of HIV-1 antibodies in fingerstick whole blood specimens.
November 7, 2002 Approval Letter
Summary of Safety and Effectiveness (PDF - 82 KB)
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448